Home

Top Stories

Dynavax (DVAX) Receives $27M Vaccine Purchase Order from CDC

(NEW YORK)–Dynavax Technologies Corp (NASDAQ: DVAX) receives $27.4 million contract purchase order from CDC for adult vaccines. DVAX receives a purchase contract from the Centers of Disease Control (CDC) for $27.4 million for adult vaccines. Some of the vaccines purchased by the CDC were: Hepatitis A adult vaccine Pneumococcal Polysaccharide vaccine Pneumococcal Conjugate (PCV13) vaccine […]

Share

 

big.chart?nosettings=1&symb=XE%3aOAL&uf=0&type=2&size=2&sid=12614224&style=320&freq=1&entitlementtoken=0c33378313484ba9b46b8e24ded87dd6&time=8&rand=180454437&compidx=&ma=0&maval=9&lf=1&lf2=0&lf3=0&height=335&width=579&mocktick=1
Share